Clinical Trials in Salt Lake City

Showing 7101-7120 of 16,694 trials

Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults

NCT03483961

The goal of this Phase 2 trial is to evaluate the immune response to and safety profile of various doses/formulations/and schedules of administration of PXVX0317 in healthy adults. Primary Objective: To assess the immune response to the vaccine Secondary Objectives: To assess the kinetics of the immune response to different doses/formulations/schedules To assess the persistence of immune responses to different doses/formulations/schedules To assess the effect of a booster dose of the vaccine Safety Objective: To assess local and systemic reactions to the vaccine and to describe the safety profile of the vaccine

Chikungunya Virus Infection

Bavarian Nordic445 participantsStarted Apr 2018

Lenexa, Kansas, United States • Kansas City, Missouri, United States • West Jordan, Utah, United States

COMPLETEDPhase 2187 miles

MP1032 Treatment in Patients With Moderate to Severe COVID-19

NCT04932941

The purpose of this study is to evaluate the efficacy and safety of MP1032 with standard of care (SoC) verses placebo with SoC in hospitalized adults participants with moderate to severe coronavirus disease 2019 (COVID-19).

COVID-19

MetrioPharm AG132 participantsStarted Oct 2021

Idaho Falls, Idaho, United States • Staten Island, New York, United States • Blagoevgrad, Bulgaria +28 more locations

Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults

MP1032 Treatment in Patients With Moderate to Severe COVID-19

Find Trials by Condition in Salt Lake City

Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer

Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma

Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer

Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes

PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)

Study to Evaluate the Safety and Efficacy of Oral CR845 (Difelikefalin) in Patients With Primary Biliary Cholangitis (PBC) and Moderate-to-Severe Pruritus

Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes

Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer

Study of Verinurad in Heart Failure With Preserved Ejection Fraction

Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours

PNT2258 for Treatment of Patients With Richter's Transformation (Brighton)

Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer

A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)

Dissemination and Implementation of Stroke Prevention Looking at the Care Environment

Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma

Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp